Compare ATRC & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | AMPX |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2005 | 2022 |
| Metric | ATRC | AMPX |
|---|---|---|
| Price | $55.75 | $7.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $55.78 | $22.10 |
| AVG Volume (30 Days) | 914.1K | ★ 5.2M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | 22.22 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $201,630,000.00 | $73,011,000.00 |
| Revenue This Year | $13.42 | $92.56 |
| Revenue Next Year | $12.12 | $50.96 |
| P/E Ratio | $311.17 | ★ N/A |
| Revenue Growth | 15.40 | ★ 202.11 |
| 52 Week Low | $25.36 | $7.29 |
| 52 Week High | $61.70 | $24.23 |
| Indicator | ATRC | AMPX |
|---|---|---|
| Relative Strength Index (RSI) | 51.56 | 29.08 |
| Support Level | $26.95 | N/A |
| Resistance Level | $61.70 | $10.60 |
| Average True Range (ATR) | 2.28 | 0.51 |
| MACD | -0.32 | -0.16 |
| Stochastic Oscillator | 56.81 | 16.82 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. Its silicon anodes are a direct drop-in replacement of the graphite anode in traditional lithium-ion batteries, and its manufacturing processes leverage the manufacturing processes for conventional lithium-ion batteries and the related supply chain.